Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

por Deng, Su, Wang, Choushi, Wang, Yunguan, Xu, Yaru, Li, Xiaoling, Johnson, Nickolas A., Mukherji, Atreyi, Lo, U-Ging, Xu, Lingfan, Gonzalez, Julisa, Metang, Lauren A., Ye, Jianfeng, Tirado, Carla Rodriguez, Rodarte, Kathia, Zhou, Yinglu, Xie, Zhiqun, Arana, Carlos, Annamalai, Valli, Liu, Xihui, Vander Griend, Donald J., Strand, Douglas, Hsieh, Jer-Tsong, Li, Bo, Raj, Ganesh, Wang, Tao, Mu, Ping
Publicado 2022

Author Correction: Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

por Deng, Su, Wang, Choushi, Wang, Yunguan, Xu, Yaru, Li, Xiaoling, Johnson, Nickolas A., Mukherji, Atreyi, Lo, U-Ging, Xu, Lingfan, Gonzalez, Julisa, Metang, Lauren A., Ye, Jianfeng, Tirado, Carla Rodriguez, Rodarte, Kathia, Zhou, Yinglu, Xie, Zhiqun, Arana, Carlos, Annamalai, Valli, Liu, Xihui, Vander Griend, Donald J., Strand, Douglas, Hsieh, Jer-Tsong, Li, Bo, Raj, Ganesh, Wang, Tao, Mu, Ping
Publicado 2022

Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer

por Li, Xiaoling, Wang, Yunguan, Deng, Su, Zhu, Guanghui, Wang, Choushi, Johnson, Nickolas A., Zhang, Zeda, Tirado, Carla Rodriguez, Xu, Yaru, Metang, Lauren A., Gonzalez, Julisa, Mukherji, Atreyi, Ye, Jianfeng, Yang, Yuqiu, Peng, Wei, Tang, Yitao, Hofstad, Mia, Xie, Zhiqun, Yoon, Heewon, Chen, Liping, Liu, Xihui, Chen, Sujun, Zhu, Hong, Strand, Douglas, Liang, Han, Raj, Ganesh, He, Housheng Hansen, Mendell, Joshua T., Li, Bo, Wang, Tao, Mu, Ping
Publicado 2023